Program Monitoring
6,925
Number of Clinics
54,654
Number of Settlements
4,875,769
Enrollments
20,404,616
Disbursements
Bauchi
1,109
9,261
689,822
2,933,793
Gombe
518
5,088
314,395
1,327,272
Jigawa
785
7,487
887,509
4,064,326
Kaduna
276
2,106
199,379
745,392
Kano
1,260
11,566
950,839
3,707,031
Katsina
1,296
6,497
1,040,539
4,687,304
Kebbi
540
2,943
216,858
806,789
Niger
331
2,758
29,795
43,763
Sokoto
380
2,922
197,698
749,507
Yobe
158
1,762
34,115
51,384
Zamfara
272
2,264
314,820
1,288,055
Vaccination Rate
95.62%
Penta 1
91.19%
Penta 2
88.21%
Penta 3
85.74%
Measles
Bauchi
95.49%
91.44%
88.63%
85.74%
Gombe
96.28%
92.88%
90.28%
87.45%
Jigawa
95.8%
92.4%
90.26%
87.75%
Kaduna
95.49%
90.56%
87.0%
82.58%
Kano
95.0%
90.98%
88.0%
84.81%
Katsina
96.22%
92.66%
90.35%
88.12%
Kebbi
95.06%
88.56%
84.23%
82.46%
Niger
93.3%
83.1%
76.24%
86.66%
Sokoto
94.24%
84.03%
77.86%
74.52%
Yobe
94.68%
89.69%
85.24%
92.93%
Zamfara
96.32%
88.7%
83.68%
83.4%
Impact Evaluation Key Findings
An independent randomized controlled trial found, among other positive findings, that New Incentives’ All Babies program:
Increased Coverage
The program doubled the percentage of infants who were fully vaccinated, increasing coverage from roughly a quarter to just over half of all infants.
Improved Timeliness
Infants who received measles vaccines were 33 percentage points more likely to receive the vaccine within one month of the recommended age.
Improved Knowledge and Attitudes
Caregivers in areas served by the program had better knowledge and more favorable attitudes toward immunization.
Reduced Stockouts
Government clinics with the program were 18 percentage points less likely to report vaccine stockouts during the last 12 months.
Randomized Controlled Trial
Expected in Dec 2020
Study with two-arm cluster RCT
- Control (83 clinics): No intervention, status quo
- Treatment (84 clinics): New Incentives full program
- This design will measure the causal effect of New Incentives' program on the likelihood of an infant receiving a vaccine.
.svg)
.svg)
.png)